Taken together, co-expression of high levels of APOBEC3A, IFI6, and IFI27 in the laryngeal SCC suggests that interferon-induced APOBEC3A upregulation could be a potential driver of therapeutic resistance to CPI in HNSCC. Here, IFI6 is linked to head and neck squamous cell carcinoma.